James Kuo

James Kuo

Founder at TRYP THERAPEUTICS INC.

Net worth: 146 760 $ as of 2024-03-30

58 year
Health Technology
Finance
Consumer Services

Profile

James S.
Kuo
was the founder of Windtree Therapeutics, Inc. (founded in 1992) and BioMicro Systems, Inc. (founded in 2003), where he held the titles of President & Chief Executive Officer and Chairman & Chief Executive Officer, respectively.
He is also the founder of Tryp Therapeutics, Inc. (founded in 2019) and currently serves as a Director.
Dr. Kuo is also the founder of Monarch Labs, Inc. Dr. Kuo's current jobs include Chairman & Chief Executive Officer at ApoLife, Inc. (since 2012), Chief Executive Officer at Return Health, Inc., Non-Executive Chairman at MSK Pharma LLC, Independent Director at Pharnext SA (starting in 2022), Managing Director at Athena Bioventures, Inc. (since 2007), and Vice President-Research & Development at Silo Pharma, Inc. (starting in 2022).
His former jobs include Chief Executive Officer & IR Contact at FIT Biotech Oy (2016-2018), Chairman & Chief Executive Officer at Cysteine Pharma, Inc. (2006-2007), Chief Executive Officer at OncoTracker, Inc. (2018-2019), Chairman & Chief Executive Officer at KMRB Acquisition Corp.
II, Non-Executive Chairman at Soligenix, Inc. (2004-2009), Chairman at ImmunoPrecise Antibodies Ltd.
(2016-2023), Associate Director-Corporate Licensing at Pfizer Inc. (1995-1997), Managing Director-Venture Analysis at HealthCare Ventures LLC, Director at Cordex Pharma, Inc. (2007-2010), Director at Theriva Biologics, Inc. (2007-2012), and Vice President-Business Development at Myriad Genetics, Inc. (1998-2000).
Dr. Kuo's education includes an undergraduate degree from Haverford College, an MBA from The Wharton School of the University of Pennsylvania, and a doctorate from the University of Pennsylvania Medical Center.
Dr. Kuo is also the founder of Monarch Labs, Inc...

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-01-08 6,000,000 ( 6.22% ) 108 000 $ 2024-03-30
2023-03-16 25,500 ( 0.10% ) 38 760 $ 2024-03-30

James Kuo active positions

CompaniesPositionStart
TRYP THERAPEUTICS INC. Founder -
PHARNEXT SCA Director/Board Member 2022-06-15
SILO PHARMA, INC. Chief Tech/Sci/R&D Officer 2022-08-31
Chief Executive Officer -
Corporate Officer/Principal 2006-12-31
Chief Executive Officer 2012-09-26
MSK Pharma LLC Chairman 2011-04-10
Founder -
All active positions of James Kuo

Former positions of James Kuo

CompaniesPositionEnd
IMMUNOPRECISE ANTIBODIES LTD. Chairman 2023-11-08
░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ -
░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
See the detail of James Kuo's experience

Training of James Kuo

Haverford College Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin
University of Pennsylvania Medical Center Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of James Kuo's experience

Connections

100 +

1st degree connections

24

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies9
SOLIGENIX, INC.

Health Technology

PFIZER, INC.

Health Technology

WINDTREE THERAPEUTICS, INC.

Health Technology

MYRIAD GENETICS, INC.

Health Technology

SILO PHARMA, INC.

Health Technology

THERIVA BIOLOGICS, INC.

Health Technology

PHARNEXT SCA

Health Technology

IMMUNOPRECISE ANTIBODIES LTD.

Health Technology

TRYP THERAPEUTICS INC.

Health Technology

Private companies12

Health Technology

Finance

Health Technology

Process Industries

Health Technology

Commercial Services

Cysteine Pharma, Inc.

MSK Pharma LLC

Finance

Finance

Health Technology

Health Technology

See company connections